$ZVRA
ZEVRA THERAPEUTICS, INC.

2018 Q3 Form 10-Q Financial Statement

#000143774918020328 Filed on November 09, 2018

View on sec.gov

Income Statement

Concept 2018 Q3 2017 Q3
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $4.230M $3.320M
YoY Change 27.41% -33.73%
% of Gross Profit
Research & Development $13.33M $6.293M
YoY Change 111.82% 46.79%
% of Gross Profit
Depreciation & Amortization $80.00K $90.00K
YoY Change -11.11% 125.0%
% of Gross Profit
Operating Expenses $17.96M $9.612M
YoY Change 86.83% -7.59%
Operating Profit -$17.96M -$9.612M
YoY Change 86.83% -7.59%
Interest Expense $1.367M $1.448M
YoY Change -5.59% 0.49%
% of Operating Profit
Other Income/Expense, Net $2.827M -$373.0K
YoY Change -857.91% -87.7%
Pretax Income -$15.13M -$9.985M
YoY Change 51.54% -25.67%
Income Tax -$60.00K -$4.000K
% Of Pretax Income
Net Earnings -$15.07M -$9.981M
YoY Change 51.0% -25.59%
Net Earnings / Revenue
Basic Earnings Per Share -$0.94 -$0.68
Diluted Earnings Per Share -$0.94 -$0.68
COMMON SHARES
Basic Shares Outstanding 16.03M
Diluted Shares Outstanding 16.03M

Balance Sheet

Concept 2018 Q3 2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.00M $45.20M
YoY Change -71.24% -28.82%
Cash & Equivalents $1.788M $7.829M
Short-Term Investments $11.20M $37.40M
Other Short-Term Assets $3.700M $2.500M
YoY Change 48.0% 47.06%
Inventory
Prepaid Expenses
Receivables $2.503M
Other Receivables $0.00
Total Short-Term Assets $16.74M $50.20M
YoY Change -66.66% -23.08%
LONG-TERM ASSETS
Property, Plant & Equipment $1.817M $2.086M
YoY Change -12.9% 43.27%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $6.700M
YoY Change -75.55%
Other Assets $183.0K $313.0K
YoY Change -41.53% -33.69%
Total Long-Term Assets $2.000M $9.116M
YoY Change -78.06% -68.87%
TOTAL ASSETS
Total Short-Term Assets $16.74M $50.20M
Total Long-Term Assets $2.000M $9.116M
Total Assets $18.74M $59.31M
YoY Change -68.41% -37.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $14.70M $6.400M
YoY Change 129.69% 14.29%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $3.500M $200.0K
YoY Change 1650.0% 100.0%
Total Short-Term Liabilities $18.32M $6.647M
YoY Change 175.66% 16.53%
LONG-TERM LIABILITIES
Long-Term Debt $87.60M $92.30M
YoY Change -5.09% 1.65%
Other Long-Term Liabilities $717.0K $1.427M
YoY Change -49.75% 173.9%
Total Long-Term Liabilities $717.0K $1.427M
YoY Change -49.75% 173.9%
TOTAL LIABILITIES
Total Short-Term Liabilities $18.32M $6.647M
Total Long-Term Liabilities $717.0K $1.427M
Total Liabilities $114.1M $107.4M
YoY Change 6.21% 2.94%
SHAREHOLDERS EQUITY
Retained Earnings -$216.0M -$154.2M
YoY Change 40.12% 38.38%
Common Stock $120.7M $106.1M
YoY Change 13.77% 4.39%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$95.35M -$48.10M
YoY Change
Total Liabilities & Shareholders Equity $18.74M $59.31M
YoY Change -68.41% -37.26%

Cashflow Statement

Concept 2018 Q3 2017 Q3
OPERATING ACTIVITIES
Net Income -$15.07M -$9.981M
YoY Change 51.0% -25.59%
Depreciation, Depletion And Amortization $80.00K $90.00K
YoY Change -11.11% 125.0%
Cash From Operating Activities -$15.96M -$10.17M
YoY Change 56.93% 22.97%
INVESTING ACTIVITIES
Capital Expenditures -$10.00K -$40.00K
YoY Change -75.0% -87.88%
Acquisitions
YoY Change
Other Investing Activities $460.0K $5.690M
YoY Change -91.92% 44.05%
Cash From Investing Activities $460.0K $5.660M
YoY Change -91.87% 56.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 780.0K -50.00K
YoY Change -1660.0% -97.5%
NET CHANGE
Cash From Operating Activities -15.96M -10.17M
Cash From Investing Activities 460.0K 5.660M
Cash From Financing Activities 780.0K -50.00K
Net Change In Cash -14.72M -4.560M
YoY Change 222.81% -31.53%
FREE CASH FLOW
Cash From Operating Activities -$15.96M -$10.17M
Capital Expenditures -$10.00K -$40.00K
Free Cash Flow -$15.95M -$10.13M
YoY Change 57.45% 27.58%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-32832000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1075000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-86000
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-60000
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-107000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-12000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5780000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1046000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
101000
CY2017Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
154000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
723000
CY2018Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
52000
CY2018Q3 us-gaap Interest Expense
InterestExpense
1367000
CY2017Q3 us-gaap Interest Expense
InterestExpense
1448000
us-gaap Interest Expense
InterestExpense
4228000
us-gaap Interest And Other Income
InterestAndOtherIncome
290000
us-gaap Interest And Other Income
InterestAndOtherIncome
268000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
52456000
CY2018Q3 us-gaap Liabilities Current
LiabilitiesCurrent
18323000
us-gaap Interest Expense
InterestExpense
4332000
us-gaap Interest Paid Net
InterestPaidNet
5280000
us-gaap Interest Paid Net
InterestPaidNet
5472000
CY2018Q3 us-gaap Liabilities
Liabilities
114082000
CY2017Q4 us-gaap Liabilities
Liabilities
109972000
CY2018Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18737000
CY2018Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
11239000
CY2017Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
31358000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4754000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-165000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
25368000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
17396000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11509000
CY2018Q3 us-gaap Long Term Investments
LongTermInvestments
CY2017Q4 us-gaap Long Term Investments
LongTermInvestments
3250000
CY2017Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
CY2018Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-15071000
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-9981000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-39205000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-26164000
us-gaap Net Income Loss
NetIncomeLoss
-51283000
us-gaap Net Income Loss
NetIncomeLoss
-32820000
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9612000
CY2018Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2827000
CY2017Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-373000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4755000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7616000
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
17958000
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
9612000
us-gaap Operating Expenses
OperatingExpenses
46635000
us-gaap Operating Expenses
OperatingExpenses
25216000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-17958000
CY2018Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
183000
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
206000
CY2018Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
103000
us-gaap Operating Income Loss
OperatingIncomeLoss
-46635000
us-gaap Operating Income Loss
OperatingIncomeLoss
-25216000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
CY2017Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
112000
CY2018Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
717000
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
794000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
21345000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
178000
CY2018Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
50000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
CY2018Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2017Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
68000
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2018Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2610000
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1662000
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
4828000
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
25374000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
38919000
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13330000
CY2017Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6293000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
4000
CY2018Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1817000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2004000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
142000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
119000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15057000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
35455000
CY2018Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1100000
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1100000
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
kmph Deferred Offering Costs Included In Accounts Payable And Accrued Expense
DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpense
68000
kmph Deferred Offering Costs Included In Accounts Payable And Accrued Expense
DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpense
60000
CY2018Q3 kmph Derivative And Warrant Liability Noncurrent
DerivativeAndWarrantLiabilityNoncurrent
7420000
CY2017Q4 kmph Derivative And Warrant Liability Noncurrent
DerivativeAndWarrantLiabilityNoncurrent
7709000
CY2018Q3 kmph Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Cumulative Effect Adjustment
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCumulativeEffectAdjustment
4468000
CY2017Q3 kmph Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Cumulative Effect Adjustment
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCumulativeEffectAdjustment
1312000
kmph Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Cumulative Effect Adjustment
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCumulativeEffectAdjustment
289000
kmph Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Cumulative Effect Adjustment
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCumulativeEffectAdjustment
-2381000
kmph Gain Loss On Subleases
GainLossOnSubleases
kmph Gain Loss On Subleases
GainLossOnSubleases
-102000
CY2018Q3 kmph Sale Of Securities Value Available To Issue
SaleOfSecuritiesValueAvailableToIssue
150000000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1123000
kmph Trade Receivables
TradeReceivables
kmph Trade Receivables
TradeReceivables
2503000
CY2018Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
14677000
CY2017Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
7875000
CY2018Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2005000
CY2018Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
120662000
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
107209000
CY2018Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2586000
CY2017Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1158000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5245000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3412000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1036000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1106000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1171000
CY2018Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
326000
CY2017Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
391000
CY2018Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11943705
CY2017Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11692856
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11943705
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11692856
CY2018Q3 us-gaap Assets
Assets
18737000
CY2017Q4 us-gaap Assets
Assets
52456000
CY2018Q3 us-gaap Assets Current
AssetsCurrent
16737000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
46996000
CY2018Q3 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
210000
CY2017Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
189000
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
52000
CY2018Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
12591977
CY2017Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
12618711
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2018Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16042018
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14657430
CY2018Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16042018
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14657430
CY2018Q3 us-gaap Common Stock Value
CommonStockValue
2000
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2018Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
87171000
CY2017Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
89398000
CY2018Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
3333000
CY2017Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
3333000
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
3502000
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
245000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
251000
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.94
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.68
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.33
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.24
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-289000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2381000
CY2018Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-4468000
CY2017Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1312000
CY2018Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
7420000
CY2017Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
6999000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
7420000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
6999000
CY2018Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
11888000
CY2017Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
8311000
CY2017Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
7709000
CY2016Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
4618000
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2992000
CY2017Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3319000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9544000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10159000
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15131000
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9985000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-51390000
CY2018Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-216009000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-164726000
CY2018Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
CY2017Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
CY2018Q3 us-gaap Severance Costs1
SeveranceCosts1
1636000
CY2017Q3 us-gaap Severance Costs1
SeveranceCosts1
us-gaap Severance Costs1
SeveranceCosts1
1636000
us-gaap Severance Costs1
SeveranceCosts1
us-gaap Share Based Compensation
ShareBasedCompensation
5245000
us-gaap Share Based Compensation
ShareBasedCompensation
3412000
us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
598568
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
762338
CY2018Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
23682
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
9750
CY2017Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
-95345000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-57516000
us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div></div> <div style=" margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">The preparation of financial statements in conformity with GAAP&nbsp;requires the Company to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</div> <div style=" margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">On an ongoing basis, the Company evaluates its estimates, including those related to the useful lives of property and equipment, and assumptions used for purposes of determining stock-based compensation, income taxes, and the fair value of the derivative and warrant liability, among others. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable, the results of which form the basis for making judgments about the carrying value of assets and liabilities.</div></div></div></div></div></div></div>
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
16033923
CY2017Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14657430
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
15385663
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14651371
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
284000
CY2018Q3 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
451000
CY2017Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
562000
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1788000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10871000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11971000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17862000
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2888000
CY2017Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8929000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-9083000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8933000
CY2018Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies

Files In Submission

Name View Source Status
0001437749-18-020328-index-headers.html Edgar Link pending
0001437749-18-020328-index.html Edgar Link pending
0001437749-18-020328.txt Edgar Link pending
0001437749-18-020328-xbrl.zip Edgar Link pending
ex_126201.htm Edgar Link pending
ex_126202.htm Edgar Link pending
ex_126203.htm Edgar Link pending
ex_126204.htm Edgar Link pending
ex_126209.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
kmph-20180930.xml Edgar Link completed
kmph-20180930.xsd Edgar Link pending
kmph-20180930_cal.xml Edgar Link unprocessable
kmph-20180930_def.xml Edgar Link unprocessable
kmph-20180930_lab.xml Edgar Link unprocessable
kmph-20180930_pre.xml Edgar Link unprocessable
kmph20180930_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending